Globus Medical GMED Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Globus Medical's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Globus Medical's investing cash flow?
- Globus Medical (GMED) reported investing cash flow of -$182.67M in Q1 2026.
- How has Globus Medical's investing cash flow changed year-over-year?
- Globus Medical's investing cash flow decreased by 239.0% year-over-year, from $131.39M to -$182.67M.
- What is the long-term trend for Globus Medical's investing cash flow?
- Over 4 years (2021 to 2025), Globus Medical's investing cash flow has grown at a -1.4% compound annual growth rate (CAGR), from -$375.94M to -$355.01M.
- What does investing cash flow mean?
- The total cash impact of all investment-related activities.
- How do you interpret investing cash flow?
- Negative values typically indicate active investment in growth, while positive values may indicate divestment or a focus on cash preservation.
- How does investing cash flow compare across companies?
- Standard across all industries; usually negative for growing companies.